Zhang Weifeng, Liu Zhiyong, Lin Weiru, Zhang Fengfeng, Xu Jinglin, Li Xiaoqing, Wang Ruiquan, Wu Lianqiang, Chen Dongmei
Graduate School, Fujian Medical University, Fuzhou, Fujian 350000, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023 Sep 10;40(9):1171-1175. doi: 10.3760/cma.j.cn511374-20220511-00320.
To explore the diagnosis, treatment and genetic characteristics of a neonate with severe pulmonary hypertension and respiratory failure.
Perinatal history, clinical manifestations, laboratory finding and diagnosis and treatment data of the child were collected. Whole exome sequencing was carried out for the child, and Sanger sequencing was used to verify the candidate variants.
The female neonate has developed progressive respiratory failure and refractory pulmonary hypertension shortly after birth. Conventional treatment such as mechanical ventilation, vasoactive drugs, and inhaled nitric oxide were ineffective. She has developed sustained pulmonary hypertension after weaning from extracorporeal membrane oxygenation therapy, and had died after the treatment had ceased. Whole exome sequencing revealed that she has harbored a heterozygous de novo variant of c.682_683insGCGGCGGC (p.G234Rfs*148) of the FOXF1 gene, which was predicted as pathogenic based on guidelines from the American College of Medical Genetics and Genomics (ACMG), with evidence items of PVS1_Strong+PM2_Supporting+PS2. Based on her clinical manifestations and result of genetic testing, the child was diagnosed with alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV).
Discovery of the c.682_683insGCGGCGGC (p.G234 Rfs*148) variant of the FOXF1 gene has expanded the mutational spectrum of the FOXF1 gene, which has facilitated implementation of specific treatment and provided a basis for clinical diagnosis and genetic counseling.
探讨1例患有严重肺动脉高压和呼吸衰竭的新生儿的诊断、治疗及遗传学特征。
收集该患儿的围产期病史、临床表现、实验室检查结果以及诊断和治疗资料。对患儿进行全外显子组测序,并采用桑格测序法验证候选变异。
该女婴出生后不久即出现进行性呼吸衰竭和难治性肺动脉高压。机械通气、血管活性药物及吸入一氧化氮等常规治疗均无效。体外膜肺氧合治疗撤机后出现持续性肺动脉高压,治疗终止后死亡。全外显子组测序显示,她携带FOXF1基因的一个杂合新发变异c.682_683insGCGGCGGC(p.G234Rfs*148),根据美国医学遗传学与基因组学学会(ACMG)的指南,该变异被预测为致病性变异,证据条目为PVS1_Strong+PM2_Supporting+PS2。根据其临床表现及基因检测结果,该患儿被诊断为伴肺静脉错位的肺泡毛细血管发育不良(ACD/MPV)。
FOXF1基因c.682_683insGCGGCGGC(p.G234Rfs*148)变异的发现扩展了FOXF1基因的突变谱,有助于实施针对性治疗,并为临床诊断和遗传咨询提供了依据。